A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues

Multiple sclerosis (MS), which is a chronic inflammatory disease of the central nervous system, still represents one of the most common causes of persisting disability with an early disease onset. Growing evidence suggests B cells to play a crucial role in its pathogenesis and progression. Over the...

Descripción completa

Detalles Bibliográficos
Autores principales: Frisch, Esther S., Pretzsch, Roxanne, Weber, Martin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Current Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609066/
https://www.ncbi.nlm.nih.gov/pubmed/33880738
http://dx.doi.org/10.1007/s13311-021-01048-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609066/
https://www.ncbi.nlm.nih.gov/pubmed/33880738
http://dx.doi.org/10.1007/s13311-021-01048-z

Ejemplares similares